Patrick G Morris - AI Profile | 人才画像

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 224 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

A Prospective Multi-Site Translational Study Investigating the Association of Gut Microbiome (GM) Diversity with Pathological Complete Response (pcr) after Neoadjuvant Treatment in Early Stage Rectal and Esophageal Cancer

Rachel Clarke,Ronan Andrew McLaughlin, Christopher Cronin,Ruth Kieran,Ciaran Devoy,Carolyn Moloney,Orla Fitzpatrick, David O'Reilly, Conor Moloney,Maciej Milewski,Kathleen Bennett,Megan Greally,Adrian Gerard Murphy,Jarushka Naidoo,Patrick G. Morris,Oscar S. Breathnach,William Grogan,Sinead Toomey,Mark Tangney,Bryan T. Hennessy

Journal of Clinical Oncologyno. 4_suppl (2025)

Cited0Views0Bibtex

Prognostic Significance of Delays in Initiation of Adjuvant Trastuzumab-Based Therapy in Patients with HER2-Positive Breast Cancer

Gavin P. Dowling,Aisling Hegarty, Gordon R. Daly, Sandra Hembrecht, Cian M. Hehir, Gavin G. Calpin, Richard Hogan, David O’Reilly, Eithne Downey,Sinead Toomey, Liam Grogan, Oscar Breathnach, Michael Allen,Patrick G. Morris,Colm Power, Leonie S. Young,Arnold D. K. Hill,Bryan T. Hennessy

Biomedicinesno. 6 (2025): 1305

Cited0Views0Bibtex

Targeting the Phosphatidylinositol-3-kinase (PI3K) and Mitogen Activated Protein Kinase (MAPK) Signalling Pathways to Enhance Chemoradiotherapy in Locally Advanced Rectal Cancer

Aoife Carr,Jonathan A Coulter,Julie Workman,Joanna Fay, Angela Farrelly,Alex J Eustace, Lindsey Bennie, Liam Grogan, Oscar Breathnach,Patrick G Morris,Deborah A McNamara,Mattia Cremona, Brian D P O'Neill,Bryan T Hennessy,Sinead Toomey

Cancer treatment and research communications (2025): 100926-100926

Cited0Views0WOSBibtex

RET Overexpression Leads to Increased Brain Metastatic Competency in Luminal Breast Cancer

JNCI Journal of the National Cancer Institute (2024)

Cited0Views0WOSBibtex

Neoadjuvant Trastuzumab Deruxtecan (T-Dxd) with Response-Directed Definitive Therapy in Early Stage HER2-positive Breast Cancer: a Phase II Study Protocol (SHAMROCK Study)

Gavin P. Dowling,Sinead Toomey,Philip Bredin,Imelda Parker,Eibhlin Mulroe,Jacinta Marron, Olivia McLoughlin,Ausra Teiserskiene,Colm Power,Anne Marie O’Shea,Megan Greally,Patrick G. Morris,Deirdre Duke,Arnold D. K. Hill,Bryan T. Hennessy

BMC CANCER（2024）

Cited3Views0WOSBibtex

Neoadjuvant Chemoradiation in Older Irish Adult Patients with Oesophageal Cancer: A Retrospective Institutional Review of Clinical Outcomes and Hematological Toxicity

Ronan Andrew McLaughlin,David McMahon, Christopher Cluxton,Orla Meave Fitzpatrick, Michael Conroy, Majid Almeraikhi, Humaid Alkaabi, Fianait Bligh,Brian O’Neill,William Robb,Mayilone Arumugasamy,Oscar Seamus Breathnach,William Grogan,Bryan T Hennessy,Adrian Murphy, Jarsuhka Naidoo,Megan Greally,Kathleen Bennett,Patrick G Morris

crossref（2024）

Cited0Views0Bibtex

Abstract PO5-01-02: A Retrospective Review of Pathological Complete Response and Toxicity Rates to a Modified Version of TCHP (paclitaxel, Trastuzumab, Pertuzumab, Carboplatin) for HER2 Positive Breast Cancer Stage II and III

Carolyn Moloney, Maggie Louise O'Connor,Caroline O'Leary, Aislinn Reilly,Simon Barry,David O'Reilly,Philip Bredin, Hadia Paryani, David Solaligue,Bryan Hennessy,Megan Greally,Patrick G. Morris

Cancer Researchno. 9_Supplement (2024): PO5-01

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn